Essex Bio-Technology Ltd. logo

Essex Bio-Technology Ltd. (1061)

Market Closed
13 Aug, 08:00
HKEX HKEX
2. 37
HKD
-0.07
-3.0738%
HKD
2.39B Market Cap
- P/E Ratio
0.14% Div Yield
311,000 Volume
- Eps
2.44 HKD
Previous Close
Add Transaction
Day Range
2.37 2.42
Year Range
2.33 6.12
Want to track 1061 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1061 closed today lower at 2.37 HKD, a decrease of -3.0738% from yesterday's close, completing a monthly decrease of -10.4167% or -0.27 HKD. Over the past 12 months, 1061 stock lost -37.5989%.
1061 pays dividends to its shareholders, with the most recent payment made on Jun 12, 2026. The next estimated payment will be in In 3 months on Dec 12, 2026 for a total of 0.07 HKD.
The last earnings report, released on Mar 24, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.

1061 Chart

People also search for

DPC Dash Ltd.
36.6 HKD
-1.0811%
Jf Smartinvest Holdings Ltd.
29 HKD
-0.9563%
Ane Cayman Inc.
12.13 HKD
-0.1646%
SSY Group Limited
2.42 HKD
-1.4286%
Tianneng Power International Limited
4.77 HKD
-1.3444%

Essex Bio-Technology Ltd. (1061) FAQ

What is the stock price today?

The current price is 2.37 HKD.

On which exchange is it traded?

Essex Bio-Technology Ltd. is listed on HKEX.

What is its stock symbol?

The ticker symbol is 1061.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.14%.

What is its market cap?

As of today, the market cap is 2.39B.

Has Essex Bio-Technology Ltd. ever had a stock split?

No, there has never been a stock split.

Essex Bio-Technology Ltd. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Hian Leng Ngiam CEO
HKEX Exchange
G31237103 CUSIP
China Country
1,426 Employees
28 May 2026 Last Dividend
- Last Split
- IPO Date

Overview

Essex Bio-Technology Limited is a distinguished investment holding company that has carved a niche in the bio-pharmaceutical industry with its innovative and effective products. Founded in 1990 and headquartered in Zhuhai, China, the company has made significant strides in developing, manufacturing, distributing, and selling bio-pharmaceutical products not just within the People's Republic of China and Hong Kong but across international borders as well. It operates through two key segments: Ophthalmic Products and Surgical Products, focusing on the research and development of basic fibroblast growth factor (bFGF) products. These products are crucial in treating cellular proliferation, differentiation, and migration, addressing a range of medical conditions. Essex Bio-Technology's commitment to quality and therapeutic efficacy is reflected in its roster of products that span various therapeutic categories and the strategic licensing agreements with Mitotech S.A. and Mitotech LLC to expand its product portfolio further.

Products and Services

  • Beifushu Series:

    These include Beifushu eye drops, Beifushu eye gel, and Beifushu unit-dose eye drops, which are specifically designed for ophthalmic use. Each product in this series is formulated to assist in the treatment and care of the eyes, providing relief and protection against various eye conditions.

  • Tobramycin and Levofloxacin Eye Drops:

    These are antibacterial eye drops used to treat bacterial infections of the eye. Tobramycin eye drops are effective against a wide range of bacteria, while Levofloxacin eye drops are used for the treatment of bacterial conjunctivitis.

  • Sodium Hyaluronate Eye Drops:

    Formulated for those suffering from dry eyes, these drops provide lubrication, thereby offering relief from the discomfort associated with dry eye syndrome.

  • Iodized Lecithin Capsules:

    These capsules are designed as a dietary supplement to help support and improve overall health.

  • Beifuji Sprays and Lyophilized Powder:

    Targeting burn and scald wounds, acute wounds, surgical incisions, chronic wounds, and for use in skin grafting among other applications, these products facilitate healing, demonstrating Essex Bio-Technology’s expertise in advanced wound care.

  • Beifuxin Gels:

    This product is instrumental in the treatment of various types of wounds, offering an effective solution for wound management and care.

  • Carisolv Dental Caries Removal Gel:

    This innovative dental product offers a minimally invasive method for the removal of dental caries, preserving healthy tooth structure while eliminating decay.

  • Mouth Wash Granules:

    Designed for oral health, these granules help in maintaining oral hygiene, preventing dental issues while keeping the mouth fresh and clean.

  • Biologic Drugs:

    Essex Bio-Technology is also involved in the development and distribution of biologic drugs, showcasing its commitment to addressing a wide array of medical conditions through advanced biopharmaceutical solutions.

Contact Information

Address: No. 88 Keji 6th Road
Phone: 86 75 6391 1188